Skin cancer cell lines

A375

Human Melanoma cell line A-375 Organism:Homo sapiens (human) Age:54 years of age Gender:Female Tissue:Skin Cell type:Malignant melanoma Growth Properties:Monolayer, adherent Description:The A-375 cell line was established by D.J. Giard in 1973.

€340.00*

A375 growing

Human Skin Melanoma cell line A-375 Organism:Homo sapiens (human) Age:54 years of age Gender:Female Tissue:Skin Cell type:Malignant melanoma Growth Properties:Monolayer, adherent Description:The A-375 cell line was established by D.J. Giard in 1973.

€600.00*

A431

Human Skin epidermoid carcinoma cell line A-431 Organism:Homo sapiens (human) Age:85 years of age Gender:Female Tissue:Skin Morphology:Epithelial, flat polygonal Celltype:Epidermoid (squamous cell) carcinoma Growth Properties:Monolayer, adherent Description:The A-431 cell line was established by D.J. Giard in 1973.

€340.00*

A431 growing

€600.00*

HS-695T

Human Skin Melanoma, amelanotic cell line HS-695T Organism:Homo sapiens (human) Ethnicity:Caucasian Age:26 years Gender:male Tissue:Skin (from metastatic site: lymph node) Morphology:epithelial Celltype:amelanotic melanoma Growth Properties:monolayer, adherent Description:HS-695T was isolated in 1973 from the lymph node metastasis of an amelanotic melanoma by A. Creasey et al. The cells had a doubling time of approximately 48 hours at passages 19 through 40 and grew moderately in semi-solid medium.

€340.00*

HS-695T growing

Human Skin Melanoma, amelanotic cell line HS-695T Organism:Homo sapiens (human) Ethnicity:Caucasian Age:26 years Gender:Male Tissue:Skin (from metastatic site: lymph node) Morphology:Epithelial Celltype:Amelanotic melanoma Growth Properties:Monolayer, adherent Description:HS-695T was isolated in 1973 from the lymph node metastasis of an amelanotic melanoma by A. Creasey et al. The cells had a doubling time of approximately 48 hours at passages 19 through 40 and grew moderately in semi-solid medium.

€600.00*

HS1-CLS

Human Skin Sarcoma cell line Organism:Homo sapiens (human) Ethnicity:Caucasian Tissue:Skin Cell type:Sarcoma Morphology:Fibroblast Growth Properties:Monolayer, adherent Description:In vitro established from a primary sarcoma.

€540.00*

HS1-CLS growing

€800.00*

IGR-1

Human Melanoma cell line IGR-1 Organism:Homo sapiens (human) Age:42 years Gender:Male Tissue:Skin Morphology:Polygonal Cell type:Malignant melanoma Growth Properties:Monolayer, adherent Description:The IGR-1 cell line has been established from the metastatic melanoma in a growing lymph node. Mutation analysis:IGR-1 cells carry a heterozygous BRAF V600K mutation, but they are wild type with respect to BRAFV600E.

€340.00*

IGR-1 growing

€600.00*

IGR-1 serum free

Human Melanoma cell line Organism:Homo sapiens (human) Age/Stage:42 years Gender:male Tissue:skin Morphology:polygonal Celltype:malignant melanoma Growth Properties:monolayer, adherent Description:The IGR-1 cell line has been established from the metastatic melanoma in a growing lymph node.

€340.00*

MEL-CLS-1

Human Skin Melanoblastoma cell line MEL-CLS-1 Organism:Homo sapiens (human) Ethnicity:Caucasian Tissue:Melanoblastoma Growth Properties:Monolayer, adherent Description:In vitro etablished from the primary Melanoblastoma by CLS.

€540.00*

MEL-CLS-1 growing

€800.00*

MEL-CLS-2

Human Melanoma cell line MEL-CLS-2 Depositor:CLS, H. Löhrke Organism:Homo sapiens (human) Ethnicity:European Tissue:Skin Cell type:Melanotic Melanoma Growth Properties:Monolayer, adherent Description:In vitro established from a primary melanotic melanoma in 1998.

€540.00*

MEL-CLS-2 growing

€800.00*

MEL-CLS-3

Human Skin malignant Melanoma cell line MEL-CLS-3 Depositor:CLS, H.Löhrke Organism:Homo sapiens (human) Ethnicity:Caucasian Tissue:Melanoma Growth Properties:Monolayer, adherent Description:In vitro established from the primary malignant melanoma MRI-H-221.

€540.00*

MEL-CLS-3 growing

€800.00*

MEL-CLS-4

Human Skin Melanosarcoma cell line MEL-CLS-4 Organism:Homo sapiens (human) Ethnicity:Caucasian Tissue:Melanosarcoma Growth Properties:Monolayer, adherent Description:Established in vitro from the metastatic melanosarcoma.

€540.00*